Dr. Michael Franco, M.D

NPI: 1902143670
Total Payments
$1,325
2024 Payments
$103.37
Companies
5
Transactions
20

Payment Breakdown by Category

Food & Beverage$1,308 (98.7%)
Education$16.90 (1.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,308 18 98.7%
Education $16.90 2 1.3%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $963.43 15 $0 (2020)
Novo Nordisk Inc $230.20 2 $0 (2022)
Boehringer Ingelheim Pharmaceuticals, Inc. $103.37 1 $0 (2024)
Allergan, Inc. $15.94 1 $0 (2021)
Eisai Inc. $11.90 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $103.37 1 Boehringer Ingelheim Pharmaceuticals, Inc. ($103.37)
2022 $109.87 1 Novo Nordisk Inc ($109.87)
2021 $15.94 1 Allergan, Inc. ($15.94)
2020 $124.83 1 AstraZeneca Pharmaceuticals LP ($124.83)
2019 $386.85 5 AstraZeneca Pharmaceuticals LP ($266.52)
2018 $453.98 9 AstraZeneca Pharmaceuticals LP ($442.08)
2017 $130.00 2 AstraZeneca Pharmaceuticals LP ($130.00)

All Payment Transactions

20 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
10/16/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $103.37 General
Category: DIABETES
04/07/2022 Novo Nordisk Inc Saxenda (Drug) Food and Beverage In-kind items and services $109.87 General
Category: Obesity
03/17/2021 Allergan, Inc. BOTOX (Biological) Food and Beverage In-kind items and services $15.94 General
Category: FACIAL AESTHETICS
03/11/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $124.83 General
Category: Cardiovascular and Metabolism
11/13/2019 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $112.62 General
Category: Cardiovascular and Metabolism
11/07/2019 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $118.68 General
Category: Cardiovascular and Metabolism
08/02/2019 AstraZeneca Pharmaceuticals LP BYDUREON (Drug) Food and Beverage In-kind items and services $13.41 General
Category: Cardiovascular and Metabolism
07/16/2019 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $120.33 General
Category: Diabetes
01/25/2019 AstraZeneca Pharmaceuticals LP FARXIGA (Drug), BYDUREON Food and Beverage In-kind items and services $21.81 General
Category: Cardiovascular and Metabolism
11/07/2018 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $123.76 General
Category: Cardiovascular and Metabolism
11/06/2018 AstraZeneca Pharmaceuticals LP BYDUREON (Drug) Food and Beverage In-kind items and services $14.39 General
Category: Cardiovascular and Metabolism
10/18/2018 AstraZeneca Pharmaceuticals LP BYDUREON (Drug) Food and Beverage In-kind items and services $11.93 General
Category: Cardiovascular and Metabolism
10/03/2018 Eisai Inc. Belviq (Drug) Education Cash or cash equivalent $11.90 General
Category: Nutrition and Weight Loss
09/19/2018 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $12.57 General
Category: Cardiovascular and Metabolism
08/29/2018 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $124.25 General
Category: Cardiovascular and Metabolism
06/05/2018 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $111.54 General
Category: Cardiovascular and Metabolism
05/09/2018 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $12.41 General
Category: Cardiovascular and Metabolism
03/07/2018 AstraZeneca Pharmaceuticals LP FARXIGA (Drug), BYDUREON Food and Beverage In-kind items and services $31.23 General
Category: Cardiovascular and Metabolism
09/27/2017 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Education In-kind items and services $5.00 General
Category: Cardiovascular and Metabolism
06/06/2017 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $125.00 General
Category: Cardiovascular and Metabolism

About Dr. Michael Franco, M.D

Dr. Michael Franco, M.D is a Family Medicine healthcare provider based in Sherman Oaks, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/14/2013. The National Provider Identifier (NPI) number assigned to this provider is 1902143670.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Franco, M.D has received a total of $1,325 in payments from pharmaceutical and medical device companies, with $103.37 received in 2024. These payments were reported across 20 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($1,308).

Practice Information

  • Specialty Family Medicine
  • Location Sherman Oaks, CA
  • Active Since 01/14/2013
  • Last Updated 01/14/2013
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1902143670

Products in Payments

  • FARXIGA (Drug) $923.70
  • Ozempic (Drug) $120.33
  • Saxenda (Drug) $109.87
  • JARDIANCE (Drug) $103.37
  • BYDUREON (Drug) $39.73
  • BOTOX (Biological) $15.94
  • Belviq (Drug) $11.90

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Sherman Oaks